Sami Al-Nadaf

Sami Al-Nadaf

Assistant Professor

Surgical & Radiological Sciences


Licenses
Diplomate of American College of Veterinary Internal Medicine subspecialty of Oncology
Education
2008, BS, North Carolina State University, Raleigh, NC
2014, DVM, North Carolina State University, Raleigh, NC
2015, Internship, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA
2018, Residency, University of California-Davis, Davis, CA
2026, MAS, University of California, Davis,
Active Research Grants
Principal Investigator, Genomic landscape of primary canine mandibular osteosarcoma., (Principal Investigator), University of California, Davis Center for Companion Animal Health.
Co-Investigator, 18FDG PET/CT for staging of canine high-grade lymphoma patients using a total-body PET/CT protocol, Ehren McLarty (Principal Investigator), University of California, Davis Center for Companion Animal Health
Principal Investigator, Scout Out Canine Hemangiosarcoma (SOCH) Study, (Principal Investigator),
Research Focus
Molecular dysregulation in naturally occurring canine cancers.
Specialty Focus
Veterinary Medical Oncology and Clinical Trials
Ten Recent Publications

2024
Burton JH, Vail DM, Willcox JL, Al-Nadaf S, Adrianowycz S, Biggs D, Hayim R, Magee K, McMahon R, Mok I, Picone AM, Ralston J, Smith BM, Uyehara R, Willis AL, Johnston SA, Thamm DH
Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs

2024
Burton JH, Johnston SA, Vail DM, Eickhoff JC, Sykes KF, Brown JR, Shen L, Gervassi A, Page RL, Willcox JL, Al-Nadaf S, Willis AL, Biggs D, Ralston J, Mok I, Kurzman ID, Huelsmeyer MK, Hayim R, Smith BM, Thamm DH
Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs.

2023
Pritchard C, Al-Nadaf S, Rebhun RB, Willcox JL, Skorupski KA, Lejeune AT
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs

2023
Burge R, Woolard KD, Willcox JL, Rebhun RB, Burton JH, Al-Nadaf S, Skorupski KA
High-Grade, Stage 2 Mast Cell Tumors: Outcome in Dogs With Local and Systemic Therapy

2023
Veluvolu S, Willcox JL, Skorupski KA, Al-Nadaf S, Rebhun R, Wittenburg LA
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high-grade multicentric lymphoma

2022
Brady RV, Choi EA, Rebhun RB, Skorupski KA, Burton JH, Al-Nadaf S, Willcox JL
Retrospective immunohistochemical investigation of suspected non-visceral leiomyosarcoma in dogs

2022
Al-Nadaf S^, Wittenburg LA, Skorupski KA, Burton JH
Population pharmacokinetics identifies rapid gastrointestinal absorption and plasma clearance of oral chlorambucil administered to cats with indolent lymphoproliferative malignancies

2022
Al-Nadaf S^, Peacott-Ricardos KS, Dickinson PJ, Rebhun RB, York D
Expression and therapeutic targeting of BMI1 in canine gliomas.

2022
Razmara AM, Wittenburg LA, Al-Nadaf S, Toedebusch RG, Meyers FJ, Toedebusch CM
Prevalence and Clinicopathologic Features of Canine Metastatic Melanoma Involving the Central Nervous System: A Retrospective Analysis and Comparative Review.

2022
Rebhun RB,York D, Cruz SM, Judge SJ, Razmara AM, Farley LE, Brady RV, Johnson EG, Burton JH, Willcox JL, Wittenburg LA, Woolard K, Dunai C, Stewart SL, Sparger EE, Withers SS, Gingrich AA, Skorupski KA, Al-Nadaf S, LeJeune AT, Culp WTN, Murphy WJ, Kent MS, Canter RJ
Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response